We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers... read more Featured Products: More products

Download Mobile App





Nova Biomedical Presents POC and Critical Care Whole Blood IVD Testing Solutions

By LabMedica International staff writers
Posted on 13 Nov 2023
Print article
Image: Nova Biomedical is exhibiting at MEDICA 2023 at Hall 3/ C16-2 (Photo courtesy of Nova Biomedical)
Image: Nova Biomedical is exhibiting at MEDICA 2023 at Hall 3/ C16-2 (Photo courtesy of Nova Biomedical)

Nova Biomedical (Waltham, MA, USA) is presenting its range of point of care (POC) and critical care whole blood in vitro diagnostic testing solutions at MEDICA 2023.

Nova Biomedical is demonstrating the Stat Profile Prime Plus Critical Care analyzer which recently received the U.S. Food and Drug Administration (FDA) 510(k) clearance for a microcapillary sample mode. Prime Plus now performs an 11-test panel including pH, PCO2, PO2, Na, K, iCa, iMg, Cl, glucose, lactate, and hematocrit with just 90 microliters of capillary blood, or a complete 22-test profile on just 135 microliters of blood. The use of small-volume microcapillary blood collection tubes with Prime Plus eliminates sample over-draws, dead volume, and sample waste from syringe or vacuum tube devices. Prime Plus comprehensive test menu enables scheduled bundling of tests to eliminate multiple sample draws, use of multiple sample containers, and amount of blood drawn for critical care testing.

Nova Biomedical’s StatStrip Glucose Hospital Meter System is also being exhibited at MEDICA 2023. The StatStrip Glucose and StatStrip Glucose/Ketone meters are specifically designed for the detection and management of dysglycemia throughout all professional healthcare settings including critical care. Also on display at the event are the StatStrip and StatStrip Xpress2 Lactate, Hemoglobin, and Hematocrit Meter Systems which provide lactate results in only 13 seconds from a 0.6 microliter capillary blood sample, and hemoglobin and hematocrit results in 40 seconds from a 1.6 microliter capillary blood sample. StatStrip Lac/Hb/Hct meter system can connect to laboratory information systems (LIS) and electronic medical records (EMR) while the Xpress2 Lac/Hb/Hct is designed for applications that do not require connectivity.

All results offer excellent correlation to laboratory reference methods and testing with a StatStrip or Xpress2 Lac/Hb/Hct meter system is as easy as glucose self-testing. StatStrip and StatStrip Xpress2 Lac/Hb/Hct systems offer fast, point-of-care (POC) testing with single-use, disposable biosensors, tiny capillary blood samples, and easy-to-read, color display screens. The meters enable rapid, affordable lactate, hemoglobin, and hematocrit testing for any size emergency department, intensive care unit, or medical unit, as well as in pre-hospital, ambulance, and military care situations.

Related Links:
Nova Biomedical 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Liquid Ready-To-Use Lp(a) Reagent
Lipoprotein (a) Reagent

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: The new AI tool can help beat brain tumors (Photo courtesy of Crystal Light/Shutterstock)

New AI Tool Classifies Brain Tumors More Quickly and Accurately

Precision in diagnosing and categorizing tumors is essential for delivering effective treatment to patients. Currently, the gold standard for identifying various types of brain tumors involves DNA methylation-based... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.